Erythropoietin in kidney disease and type 2 diabetes.
Sandra
S
Donnelly
D000740:Anemia / Q000188:drug therapy; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D000068256:Darbepoetin alfa; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D004921:Erythropoietin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006442:Glycated Hemoglobin / Q000378:metabolism; D006397:Hematinics / Q000627:therapeutic use; D006801:Humans; D006943:Hyperglycemia / Q000150:complications*; D007676:Kidney Failure, Chronic / Q000150:complications*
D000068256:Darbepoetin alfa; D004921:Erythropoietin; D006442:Glycated Hemoglobin; D006397:Hematinics